Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL. FitzGerald LM, et al. Among authors: stanford jl. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1196-203. doi: 10.1158/1055-9965.EPI-10-1299. Epub 2011 Apr 5. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21467234 Free PMC article. Clinical Trial.
Vitamin D receptor gene polymorphisms and prostate cancer risk.
Cheteri MB, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, Langlois MC, Feng Z, Ostrander EA. Cheteri MB, et al. Among authors: stanford jl. Prostate. 2004 Jun 1;59(4):409-18. doi: 10.1002/pros.20001. Prostate. 2004. PMID: 15065089
Finding prostate cancer susceptibility genes.
Ostrander EA, Markianos K, Stanford JL. Ostrander EA, et al. Among authors: stanford jl. Annu Rev Genomics Hum Genet. 2004;5:151-75. doi: 10.1146/annurev.genom.5.061903.180044. Annu Rev Genomics Hum Genet. 2004. PMID: 15485346 Review.
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, Hod E, Katz A, Isaacs WB, Hebbring S, Komiya A, McDonnell SK, Wiley KE, Jacobsen SJ, Isaacs SD, Walsh PC, Zheng SL, Chang BL, Friedrichsen DM, Stanford JL, Ostrander EA, Chinnaiyan AM, Rubin MA, Xu J, Thibodeau SN, Friedman SL, Martignetti JA. Narla G, et al. Among authors: stanford jl. Cancer Res. 2005 Feb 15;65(4):1213-22. doi: 10.1158/0008-5472.CAN-04-4249. Cancer Res. 2005. PMID: 15735005
IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer.
Friedrichsen DM, Hawley S, Shu J, Humphrey M, Sabacan L, Iwasaki L, Etzioni R, Ostrander EA, Stanford JL. Friedrichsen DM, et al. Among authors: stanford jl. Prostate. 2005 Sep 15;65(1):44-51. doi: 10.1002/pros.20259. Prostate. 2005. PMID: 15800934
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. Ewart-Toland A, et al. Among authors: stanford jl. Carcinogenesis. 2005 Aug;26(8):1368-73. doi: 10.1093/carcin/bgi085. Epub 2005 Mar 31. Carcinogenesis. 2005. PMID: 15802297
603 results